The Valley Desk

NCT00657267 · Interventional trial

Dose-Intense Temozolomide in Recurrent Glioblastoma

Overall registry status Completed

Phase 2

Conditions Glioblastoma, Gliosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov